Trial Profile
Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis Under Conditions of Standard Practice in the Czech Republic
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2013
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- Sponsors Ferring Pharmaceuticals
- 19 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Jan 2012 New trial record